An assessment of the analytical performance of non‐invasive prenatal testing (NIPT) in detecting sex chromosome aneuploidies: 34, 717‐patient sample in a single prenatal diagnosis Centre in China. (14th June 2021)

• Record Type: Journal Article
• Authors: Luo, Yanmei; Hu, Huamei; Zhang, Rong; Ma, Yongyi; Pan, Yan; Long, Yang; Hu, Bin; Yao, Hong; Liang, Zhiqing
• Is Part Of: Journal of gene medicine. Volume 23:Number 9(2021)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2021-06-14
• Subjects: clinical application value -- non‐invasive prenatal testing -- sex chromosome aneuploidy; Genetic transformation -- Periodicals; Gene Transfer -- Periodicals; Gene Therapy -- Periodicals; 616.042
• DOI: 10.1002/jgm.3362
• Languages: English
• ISSNs: 1099-498X

Abstract

Abstract: Objective: The present study aimed to evaluate the efficacy of a non‐invasive prenatal test (NIPT) in the detection of the sex chromosome aneuploidies (SCAs) at our prenatal diagnosis centre. Methods: Among a cohort of 34, 717 pregnancies, maternal plasma samples from our prenatal diagnosis centre were subject to analysis of SCAs using NIPT detection. Pregnant women with NIPT positive results of SCAs were recommended to undergo an invasive prenatal diagnosis (i.e. karyotyping and fluorescence in situ hybridization) to validate the prediction value of NIPT. Results: From 34, 717 clinical pregnancies, 229 (0.66%) pregnancies were identified with SCAs. Of these, 78 (34.1%) cases were positive for 45, X and 151 (65.9%) cases comprised a sex chromosome trisomy. Of the 229 positive NIPT results, 193 (84.3%) cases had accepted an invasive diagnosis involving karyotyping analysis of the amniotic fluid, which confirmed 67 cases (34.7%) as true positive, as well as 126 cases (65.3%) as false positive. The positive predictive values were 23.07%, 50%, 36% and 27.27% respectively. The remaining 36 (15.7%) cases declined a prenatal diagnosis. The termination rates of 45, X, 47, XXY, 47, XXX and 47, XYY were 20.5%, 46%, 12.9% and 11.5% respectively. Conclusions: NIPT demonstrated a lower accuracy in predicting monosomy X than sex chromosome trisomies. After invasive testing, the fetal chromosome with 45, X and 47, XXY were terminated more often than those with 47, XXX, 47, XYY. Because NIPT is a screening test, false positive/negative cases exist, and pre‐ and post‐test counselling is essential for informing patients about the benefits and limitations of the test. Confirmatory testing of abnormal results is recommended prenatally or after birth, and the importance of confirmatory testing and benefits of early diagnosis should be addressed. Abstract : A non‐invasive prenatal test (NIPT) can analyze sex chromosomes, although challenges still exist wit respect to accurate detection. The expansion of screening for sex chromosome aneuploidies (SCAs) has been shown to reduce the positive predictive value of SCAs in different cohorts. Because NIPT is a screening test, confirmatory testing of abnormal results is recommended prenatally or after birth. We investigated the performance of NIPT with respect to screening for SCAs with a large cohort of consecutive pregnancies.